Acquisition by Foster Robert T of 44082 shares of Hepion Pharmaceuticals subject to Rule 16b-3
| HEPADelisted Stock | USD 0.11 0.01 8.33% |
About 61% of Hepion Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Hepion Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Hepion Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Hepion Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Hepion |
Filed transaction by Hepion Pharmaceuticals Officer Chief Scientific Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Hepion Pharmaceuticals Fundamental Analysis
We analyze Hepion Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hepion Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hepion Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Hepion Pharmaceuticals is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Hepion Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hepion Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Hepion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hepion Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Hepion Pharmaceuticals Related Equities
| ENVB | Enveric Biosciences | 5.17 | ||||
| TECX | Tectonic Therapeutic, | 3.07 | ||||
| SONN | Sonnet Biotherapeutics | 2.66 | ||||
| PSTV | Plus Therapeutics | 2.08 | ||||
| PHIO | Phio Pharmaceuticals | 0.97 | ||||
| HOTH | Hoth Therapeutics | 0.78 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Hepion Stock
If you are still planning to invest in Hepion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hepion Pharmaceuticals' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |